Posted on June 6, 2018June 8, 2018 by Pulse AssentISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis Link: ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis Source: BSI Standards Related Posts:New laws to introduce digital labelling for…Small businesses benefitting more than ever from…Government backs SMEs with new Help to Grow campaign…UK government sets out AI Safety Summit ambitionsExpert regional innovation hubs given £75 million…
